| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |